Chemed Corporation (CHE) Can’t Burn Your Long Portfolio. Just Reaches 52-Week High

April 17, 2018 - By Winifred Garcia

Investors sentiment decreased to 0.96 in 2017 Q4. Its down 0.08, from 1.04 in 2017Q3. It fall, as 18 investors sold Chemed Corporation shares while 94 reduced holdings. 49 funds opened positions while 58 raised stakes. 14.86 million shares or 3.45% less from 15.40 million shares in 2017Q3 were reported.
Eulav Asset Mngmt has invested 0.37% in Chemed Corporation (NYSE:CHE). State Street owns 450,656 shares or 0.01% of their US portfolio. Moreover, Stratos Wealth Prns Limited has 0% invested in Chemed Corporation (NYSE:CHE). Voya Management Limited Liability Co has invested 0.14% in Chemed Corporation (NYSE:CHE). California-based Palo Inc has invested 1.13% in Chemed Corporation (NYSE:CHE). Fifth Third Retail Bank accumulated 543 shares. Boston Advisors Ltd has invested 0.12% in Chemed Corporation (NYSE:CHE). Advisors Asset Mgmt has invested 0.02% in Chemed Corporation (NYSE:CHE). Smith Asset Limited Partnership stated it has 19,526 shares or 0.15% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Chemed Corporation (NYSE:CHE). Macquarie Group Incorporated Ltd holds 0% or 172 shares in its portfolio. Advisory Svcs Ltd Company holds 0% or 21 shares. Gabelli Funds Ltd Liability Company holds 230,100 shares. 1,900 are held by Iowa Bankshares. Eqis accumulated 0.06% or 4,646 shares.

Since October 30, 2017, it had 0 buys, and 5 selling transactions for $4.34 million activity. Another trade for 750 shares valued at $166,568 was made by Dallob Naomi C on Monday, October 30. Shares for $117,485 were sold by SAUNDERS DONALD E.

The stock of Chemed Corporation (NYSE:CHE) hit a new 52-week high and has $313.89 target or 9.00 % above today’s $287.97 share price. The 6 months bullish chart indicates low risk for the $4.59B company. The 1-year high was reported on Apr, 17 by If the $313.89 price target is reached, the company will be worth $413.19M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.56% or $1.61 during the last trading session, reaching $287.97. About 23,712 shares traded. Chemed Corporation (NYSE:CHE) has risen 48.33% since April 17, 2017 and is uptrending. It has outperformed by 36.78% the S&P500.

Chemed Corporation (NYSE:CHE) Ratings Coverage

Among 3 analysts covering Chemed (NYSE:CHE), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Chemed has $258.0 highest and $225 lowest target. $241.50’s average target is -16.14% below currents $287.97 stock price. Chemed had 3 analyst reports since October 26, 2017 according to SRatingsIntel. RBC Capital Markets maintained Chemed Corporation (NYSE:CHE) on Friday, February 16 with “Hold” rating. On Thursday, October 26 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. The stock of Chemed Corporation (NYSE:CHE) has “Outperform” rating given on Friday, October 27 by Oppenheimer.

Chemed Corporation provides hospice and palliative care services in the United States. The company has market cap of $4.59 billion. It operates through two divisions, VITAS and Roto-Rooter. It has a 49.14 P/E ratio. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Chemed Corporation (NYSE:CHE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.